nanopore sequencing
Variantyx Combines Long Nanopore, Short Illumina Reads for Rare Disease Whole-Genome Diagnostic Test
Premium
The firm recently launched the Genomic Unity 2.0 assay, which it claims is the first commercial diagnostic rare disease test to include nanopore sequencing.
The company’s research-use-only AmplideX Nanopore Carrier Plus kit can interrogate 11 genes underpinning nine common carrier screening conditions.
Building on previous research, the team has developed the test and implemented it clinically throughout Europe.
Gates Foundation Awards Multiple Omics, Dx Grants in April, May
Awardees include the National Institute of Standards and Technology, Detect-Ion, the US Food and Drug Administration, and the Wellcome Sanger Institute.
Renovaro Subsidiary GediCube to Acquire Majority of Liquid Biopsy Firm Cyclomics
The combined companies will advance Cyclomics' platform for cancer screening, recurrence detection, and therapy personalization.